Potential gene therapy carriers created that mimic viruses, without the risk

Chemists at Washington University in St. Louis have created tiny synthetic polymer particles that mimic viruses and show potential for a new direction in gene therapy and other potential biomedical applications.

The "nano" particle (a nanometer is roughly one-billionth of a yard) has the unlikely name of knedel (k-ned-l) because of its similarity to a popular Polish dumpling filled either with meat or sweets. The knedels are shell cross-linked structures surrounding a hydrophobic, or water insoluble, core domain. Needless to say, the knedels are too small to see with the naked eye. They have diameters ranging from 10 to 100 nanometers, so that they are of similar size to many globular proteins and viruses. In the body, they are expected to escape detection by the immune system.

Karen L. Wooley, Ph.D., professor of chemistry in Arts & Sciences, recently announced that she and her Washington University colleagues, Jianquan Liu, Ph.D., and Qi Zhang, Ph.D., both research assistants in chemistry, and Tomasz Kowaleski, Ph.D., research assistant professor in chemistry, have successfully hollowed out the knedel core to produce "nanocages" and attached a fluorescent tag to the core. They also attached a polypeptide called protein transduction domain (PTD) to the exterior of the nanostructure. They got this idea from Steven F. Dowdy, Ph.D., assistant professor of pathology at the Washington University School of Medicine in St. Louis. Dowdy demonstrated the efficiency with which PTD transduces proteins into cells.

With the aid of extremely powerful microscopes, Wooley and her colleagues were able to detect the peptide-bearing knedels binding to cell surfaces. Another group of nanoparticles without the PTD but with the fluorescent tags did not bind to target cells.

'New territory'

The accomplishment is a step toward using the knedel nanoparticles as potential gene therapy carriers, or vectors. Most gene therapy attempts today use live viruses th

Contact: Tony Fitzpatrick
Washington University in St. Louis

Page: 1 2 3

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Potential blood test for colon cancer risk
3. Potential new treatment for Gaucher disease developed by scientists at Scripps Research Institute
4. Potential cause of arthritis discovered
5. Potential of regenerative medicine explored
6. Potential therapy reported for children, adults with end-stage liver disease
7. Potential allergy vaccine boosts hope for sufferers
8. Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
9. Potential new anthrax therapy discovered
10. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:

(Date:7/1/2020)... ... July 01, 2020 , ... ... completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the ... clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers ...
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
(Date:6/23/2020)... ... 23, 2020 , ... First Aid Africa, a Scottish charity ... and manufacturer of innovative portable renewable energy equipment, have announced the success of ... COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD portable solar power ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... of Technology (MIT) has expanded the company’s exclusive license to include clinical ... the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ ...
(Date:7/7/2020)... DIEGO (PRWEB) , ... July 06, 2020 , ... R3 ... new program featuring up to 200 million stem cells. Depending on the patient's condition, ... seniors in the US will die having some form of Alzheimers dementia, and the ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... procured purchasing contracts to its membership, recently named BioFit Engineered Products ... the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... are racing to develop a vaccine or drug treatment. In an effort to ... has publicly released the world’s largest imaging dataset portraying therapeutic compound effects ...
Breaking Biology Technology:
Cached News: